drugset / Trial / NCT00828542
Safety of the Etonogestrel-releasing Implant During the Puerperium of Healthy Women
RandomizedParallel-groupOpen-labelSupportive care
Summary
The purpose of this study to assess the safety of the etonogestrel-releasing subdermal implant (Implanon) inserted during the immediate puerperium of healthy women.
Timeline
- Start
- 2007-07
- Primary completion
- 2008-02
- Completion
- 2008-02
Publications
- Results Brito MB, Ferriani RA, Quintana SM, Yazlle ME, Silva de Sa MF, Vieira CS. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception. 2009 Dec;80(6):519-26. doi: 10.1016/j.contraception.2009.05.124. Epub 2009 Jul 10.
- Results Brito MB, Ferriani RA, Meijers JC, Garcia AA, Quintana SM, Silva de Sa MF, Vieira CS. Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: a randomized controlled trial. Thromb Res. 2012 Sep;130(3):355-60. doi: 10.1016/j.thromres.2012.03.029. Epub 2012 Apr 28.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etonogestrel | Unknown | 68 mg | Subcutaneous |
| Comparator | medroxyprogesterone acetate | Other / unclassified | 150 mg | Intramuscular |
Indications
No indication recorded.